Business
SARS: Q2 2025 saw revenue growth and higher order intake, but losses and equity declined
SARS: Q2 2025 saw revenue growth and higher order intake, but losses and equity declined
About this update from Sarsys Ab
Revenue grew 14% in Q2 2025 with improved operating loss, while order intake surged 71% year-over-year. Despite a challenging market and a subsidiary's reconstruction, a successful rights issue strengthened liquidity. Gross margin and equity declined.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.